Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 6/2010

01-12-2010 | Case Report

Acute hepatic failure secondary to extensive hepatic replacement by metastatic amelanotic melanoma: an autopsy case report

Authors: Takayuki Fusasaki, Ryoichi Narita, Masaaki Hiura, Shintaro Abe, Akinari Tabaru, Ryosuke Hino, Atsuji Matsuyama, Shohei Shimajiri, Yoshiki Tokura, Yasuyuki Sasaguri, Masaru Harada

Published in: Clinical Journal of Gastroenterology | Issue 6/2010

Login to get access

Abstract

Metastatic malignant melanoma (MM) of the liver evolving into acute hepatic failure is a rare occurrence. We describe the case of an 82-year-old man with a history of MM on the left thumb treated with amputation and chemotherapy 40 months previously. On admission, he had abdominal pain, weight loss, lethargy and jaundice. Radiologic investigations such as enhanced computed tomography and abdominal ultrasound failed to establish an etiologic diagnosis. A liver biopsy revealed amelanotic melanoma cells diffusely infiltrating the hepatic parenchyma. His liver injury progressed and the patient died of hepatic failure on the 13th hospital day. Autopsy revealed >70% infiltration by metastatic amelanotic melanoma in the liver.
Literature
1.
go back to reference Rose DM, Essner R, Hughes TM, Tang PC, Bilchik A, Wanek LA, Thompson JF, Morton DL. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg. 2001;136:950–5.CrossRefPubMed Rose DM, Essner R, Hughes TM, Tang PC, Bilchik A, Wanek LA, Thompson JF, Morton DL. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg. 2001;136:950–5.CrossRefPubMed
2.
go back to reference Bouloux PM, Scott RJ, Goligher JE, Kindell C. Fulminant hepatic failure secondary to diffuse liver infiltration by melanoma. J R Soc Med. 1986;79:302–3.CrossRefPubMedPubMedCentral Bouloux PM, Scott RJ, Goligher JE, Kindell C. Fulminant hepatic failure secondary to diffuse liver infiltration by melanoma. J R Soc Med. 1986;79:302–3.CrossRefPubMedPubMedCentral
3.
go back to reference Kaplan GG, Medlicott S, Culleton B, Laupland KB. Acute hepatic failure and multi-system organ failure secondary to replacement of the liver with metastatic melanoma. BMC Cancer. 2005;5:67.CrossRefPubMedPubMedCentral Kaplan GG, Medlicott S, Culleton B, Laupland KB. Acute hepatic failure and multi-system organ failure secondary to replacement of the liver with metastatic melanoma. BMC Cancer. 2005;5:67.CrossRefPubMedPubMedCentral
4.
go back to reference Montero JL, Muntane J, de las Heras S, Ortega R, Fraga E, De la Mata M. Acute liver failure caused by diffuse hepatic melanoma infiltration. J Hepatol. 2002;37:540–1.CrossRefPubMed Montero JL, Muntane J, de las Heras S, Ortega R, Fraga E, De la Mata M. Acute liver failure caused by diffuse hepatic melanoma infiltration. J Hepatol. 2002;37:540–1.CrossRefPubMed
5.
go back to reference Rubio S, Barbero-Villares A, Reina T, Nieto S, Mendoza J, Garcia-Buey L. Rapidly-progressive liver failure secondary to melanoma infiltration. Gastroenterol Hepatol. 2005;28:619–21.CrossRefPubMed Rubio S, Barbero-Villares A, Reina T, Nieto S, Mendoza J, Garcia-Buey L. Rapidly-progressive liver failure secondary to melanoma infiltration. Gastroenterol Hepatol. 2005;28:619–21.CrossRefPubMed
6.
go back to reference Shan GD, Xu GQ, Chen LH, Wang ZM, Jin EY, Hu FL, Li YM. Diffuse liver infiltration by melanoma of unknown primary origin: one case report and literature review. Intern Med. 2009;48:2093–6.CrossRefPubMed Shan GD, Xu GQ, Chen LH, Wang ZM, Jin EY, Hu FL, Li YM. Diffuse liver infiltration by melanoma of unknown primary origin: one case report and literature review. Intern Med. 2009;48:2093–6.CrossRefPubMed
7.
go back to reference Tanaka M, Watanabe S, Masaki T, Kurokohchi K, Kinekawa F, Inoue H, Uchida N, Kuriyama S. Fulminant hepatic failure caused by malignant melanoma of unknown primary origin. J Gastroenterol. 2004;39:804–6.CrossRefPubMed Tanaka M, Watanabe S, Masaki T, Kurokohchi K, Kinekawa F, Inoue H, Uchida N, Kuriyama S. Fulminant hepatic failure caused by malignant melanoma of unknown primary origin. J Gastroenterol. 2004;39:804–6.CrossRefPubMed
8.
go back to reference Te HS, Schiano TD, Kahaleh M, Lissoos TW, Baker AL, Hart J, Conjeevaram HS. Fulminant hepatic failure secondary to malignant melanoma: case report and review of the literature. Am J Gastroenterol. 1999;94:262–6.CrossRefPubMed Te HS, Schiano TD, Kahaleh M, Lissoos TW, Baker AL, Hart J, Conjeevaram HS. Fulminant hepatic failure secondary to malignant melanoma: case report and review of the literature. Am J Gastroenterol. 1999;94:262–6.CrossRefPubMed
9.
go back to reference Harrison HB, Middleton HM 3rd, Crosby JH, Dasher MN Jr. Fulminant hepatic failure: an unusual presentation of metastatic liver disease. Gastroenterology. 1981;80:820–5.CrossRefPubMed Harrison HB, Middleton HM 3rd, Crosby JH, Dasher MN Jr. Fulminant hepatic failure: an unusual presentation of metastatic liver disease. Gastroenterology. 1981;80:820–5.CrossRefPubMed
10.
go back to reference Rowbotham D, Wendon J, Williams R. Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases. Gut. 1998;42:576–80.CrossRefPubMedPubMedCentral Rowbotham D, Wendon J, Williams R. Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases. Gut. 1998;42:576–80.CrossRefPubMedPubMedCentral
11.
go back to reference Uchiyama S, Imamura N, Ohuchida J, Hiyoshi M, Nagano M, Marutsuka K, Akiyama Y, Chijiiwa K. Late recurrence of malignant melanoma in the duodenum. Hepatogastroenterology. 2008;55:1619–21.PubMed Uchiyama S, Imamura N, Ohuchida J, Hiyoshi M, Nagano M, Marutsuka K, Akiyama Y, Chijiiwa K. Late recurrence of malignant melanoma in the duodenum. Hepatogastroenterology. 2008;55:1619–21.PubMed
12.
go back to reference Slattery E, O’Donoghue D. Metastatic melanoma presenting 24 years after surgical resection: a case report and review of the literature. Cases J. 2009;2:189.CrossRefPubMedPubMedCentral Slattery E, O’Donoghue D. Metastatic melanoma presenting 24 years after surgical resection: a case report and review of the literature. Cases J. 2009;2:189.CrossRefPubMedPubMedCentral
13.
go back to reference Berman C, Reintgen D. Radiologic imaging in malignant melanoma: a review. Semin Surg Oncol. 1993;9:232–8.CrossRefPubMed Berman C, Reintgen D. Radiologic imaging in malignant melanoma: a review. Semin Surg Oncol. 1993;9:232–8.CrossRefPubMed
15.
go back to reference Matusiak L, Bieniek A, Wozniak Z, Szepietowski JC. Amelanotic malignant melanoma in an acral location. Acta Dermatovenerol Alp Panonica Adriat. 2008;17:72–4. Matusiak L, Bieniek A, Wozniak Z, Szepietowski JC. Amelanotic malignant melanoma in an acral location. Acta Dermatovenerol Alp Panonica Adriat. 2008;17:72–4.
16.
go back to reference Huvos AG, Shah JP, Goldsmith HS. A clinicopathologic study of amelanotic melanoma. Surg Gynecol Obstet. 1972;135:917–20.PubMed Huvos AG, Shah JP, Goldsmith HS. A clinicopathologic study of amelanotic melanoma. Surg Gynecol Obstet. 1972;135:917–20.PubMed
17.
go back to reference Ramsay JA, From L, Iscoe NA, Kahn HJ. MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas. J Invest Dermatol. 1995;105:22–6.CrossRefPubMed Ramsay JA, From L, Iscoe NA, Kahn HJ. MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas. J Invest Dermatol. 1995;105:22–6.CrossRefPubMed
Metadata
Title
Acute hepatic failure secondary to extensive hepatic replacement by metastatic amelanotic melanoma: an autopsy case report
Authors
Takayuki Fusasaki
Ryoichi Narita
Masaaki Hiura
Shintaro Abe
Akinari Tabaru
Ryosuke Hino
Atsuji Matsuyama
Shohei Shimajiri
Yoshiki Tokura
Yasuyuki Sasaguri
Masaru Harada
Publication date
01-12-2010
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 6/2010
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-010-0181-x

Other articles of this Issue 6/2010

Clinical Journal of Gastroenterology 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.